Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Healthcare AI leader Desheng Biotech (2526.HK) opens subscription today, entry fee HK$5681.73
Gelonghui March 20 | The world’s only and largest parameter-scale AI medical imaging foundation model pioneer, DeShi Bio (2526.HK), is opening its IPO from today until next Wednesday (March 25). It will issue 7.9992 million H-shares, with 10% available for Hong Kong public offering and 90% for international placement. The offer price ranges from HKD 95.6 to HKD 112.5 per share, raising up to HKD 900 million. A board lot is 50 shares, with an entry fee of HKD 5,681.73. Shares are expected to list on March 30. Huatai International is the sole sponsor.
The company plans to allocate approximately 49% of the net proceeds to the R&D and commercialization of its core product, AI AutoVision; about 10% to other medical imaging software candidate products and medical devices R&D; around 20% to strengthening the iMedImage foundation model and AI technology, as well as enhancing technology licensing business; approximately 8% to expanding commercialization capabilities and market penetration in China; about 5% to expanding global market operations; and roughly 8% to seeking strategic cooperation and investment opportunities with upstream and downstream participants in the medical value chain.